ESC 365 - Factor XI inhibition – are NOACs obsolete? Mechanistic and pharmacological insights

EHRA Premium Access

Factor XI inhibition – are NOACs obsolete? Mechanistic and pharmacological insights

Session: The new frontier in oral anticoagulation: Factor XIa inhibitors

Topic: Stroke Prevention

Speaker: Doctor J. Weitz (Hamilton, CA)

Event: EHRA 2023

Congress Presentation

Add to my library

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

31 presentations

1 follower

4 more presentations in this session

This programme is supported by Bayer Pharma AG in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor

Non-vitamin K antagonist oral anticoagulants (NOACs) – Limitations and new opportunities

Speaker: Professor J. Steffel (Zurich, CH)

Factor XI inhibition – the new paradigm for atrial fibrillation and stroke

Speaker: Professor G. Lip (Liverpool, GB)

Factor XI inhibition – other indications: acute coronary syndrome, venous thromboembolism

Speaker: Professor D. Capodanno (Catania, IT)

Access the full session

The new frontier in oral anticoagulation: Factor XIa inhibitors

Speakers: Doctor J. Weitz, Professor J. Steffel, Professor G. Lip, Professor D. Capodanno

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources